ARTV
Artiva Biotherapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.61
+2.01%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.54
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.63
- EPS estimate
- -$0.63
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -2.0%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.63 | -$0.63 | Miss -0.79% | — |
| May 8, 2026 | -$0.88 | -$0.95 | Miss -7.95% | — |
| Nov 12, 2025 | -$0.92 | -$0.88 | Beat 4.35% | — |
| Aug 6, 2025 | -$0.84 | -$0.87 | Miss -3.57% | — |
| May 8, 2025 | -$0.68 | -$0.83 | Miss -22.06% | — |
| Mar 25, 2025 | -$0.71 | -$0.66 | Beat 7.04% | — |
| Aug 29, 2024 | -$4.40 | -$22 | Miss -400.00% | $251.0K |
| Jun 29, 2024 | — | -$0.62 | — | — |
| Dec 30, 2023 | — | -$0.30 | — | $33.5M |
| Sep 30, 2023 | — | $1.20 | — | $26.7M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026